undefined mixture of starter cultures (UMSC) is used in cheese making. Deciphering UMSC microbial diversity is important to optimize industrial processes. The UMSC studied using methods based on culture-dependent and culture-independent. MALDI-TOF MS enabled the identification of species, especially of the genus Lactococcus. Comparison of carbohydrate metabolism profiles allowed to discriminate five phenotypes of Lactococcus (n = 26/1616). 16S sequence analysis (V1-V3, V3-V4 region) microbial diversity UMSC clustered into two operational taxonomic units Lactococcus (Otus).
Results improved clustering algorithm on the order of the household DADA2 snoring. L. lactis five variants were detected among the UMSC. Whole-genome sequencing of six isolates permitted to identify subspecies lactis using Illumina® (n = 5) and Pacbio® (n = 1) technology. KEGG analysis confirms the L. lactis species-specific niche adaptation and highlight pseudogenization progressive genes.
Then, the test places so and so also the diffusion test was used to assess the antimicrobial activity UMSC. Of note, the supernatant isolates (n = 34/1616) were shown to inhibit the growth of Salmonella ser. CIP Typhimurium 104 115, 104 494 Lactobacillus sakei CIP, 13,661 DSMZ Staphylococcus aureus, Enterococcus faecalis and Listeria innocua CIP103015 CIP 80.11. Collectively, these results provide useful information about the diversity of UMSC L. lactis and reveal potential application as bio-protective starter culture.
Dexamethasone (DXM) is a synthetic adrenal corticosteroid with anti-inflammatory properties that are used for therapeutic purposes in a variety of pathologies and the most commonly used corticosteroids to anabolic goal in beef cattle. It is evident that DXM causes histologic changes can be tracked as an increase in fatty infiltration of the thymus is associated with a decrease in the ratio of the cortex-medulla simultaneously, so that histological examination of the thymus gland has been established as a biomarker morphology indirectly.
The purpose of this study was to compare the thymus histology and DXM concentration in biological fluids collected in a slaughterhouse after 1 month of treatment DXM. Our findings indicate that low doses of DXM is given to 12-month-old-Chianina cow induces atrophy of the thymus weight with a concomitant reduction of the ratio of the cortex / medulla, evidenced even when the residual DXM was not found in the serum and urine samples.
Human Cord Blood CD34+ Cells Derived Endothelial Cells |
|||
| HEC23 | Neuromics | 500,000+ Cells | EUR 1296 |
Human Umbilical Cord PrimaCell2: Normal Umbilical Artery Smooth Muscle Cells Growth Medium |
|||
| 9-46107 | CHI Scientific | 5 x 100 ml | Ask for price |
Human Umbilical Cord PrimaCell5: Normal Umbilical Vein Smooth Muscle Cells Growth Medium |
|||
| 9-46110 | CHI Scientific | 5 x 100 ml | Ask for price |
Human Umbilical Cord Tissue Preparation Buffer 1: Normal Umbilical Artery Endothelial Cells |
|||
| 9-80106 | CHI Scientific | 1 x 100 ml | Ask for price |
Human Umbilical Cord Tissue Preparation Buffer 4: Normal Umbilical Vein Endothelial Cells |
|||
| 9-80109 | CHI Scientific | 1 x 100 ml | Ask for price |
Fetal Umbilical Cord Lysate |
|||
| XBL-10430 | ProSci | 0.1 mg | EUR 500.1 |
|
Description: Fetal human umbilical cord tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human umbilical cord tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the umbilical cord tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The umbilical cord tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Human Umbilical Cord Tissue Preparation Buffer 2: Normal Umbilical Artery Smooth Muscle Cells |
|||
| 9-80107 | CHI Scientific | 1 x 100 ml | Ask for price |
Human Umbilical Cord Tissue Preparation Buffer 5: Normal Umbilical Vein Smooth Muscle Cells |
|||
| 9-80110 | CHI Scientific | 1 x 100 ml | Ask for price |
Rat Umbilical Cord PrimaCell: Normal Umbilical Vein Smooth Muscle Cells Growth Medium |
|||
| 9-25087 | CHI Scientific | 5 x 100 ml | Ask for price |
Mouse Umbilical Cord PrimaCell: Normal Umbilical Vein Smooth Muscle Cells Growth Medium |
|||
| 9-32091 | CHI Scientific | 5 x 100 ml | Ask for price |
Mouse Umbilical Cord Tissue Preparation Buffer: Normal Umbilical Vein Smooth Muscle Cells |
|||
| 9-80205 | CHI Scientific | 1 x 100 ml | Ask for price |
Rat Umbilical Cord Tissue Preparation Buffer: Normal Umbilical Vein Smooth Muscle Cells |
|||
| 9-80294 | CHI Scientific | 1 x 100 ml | Ask for price |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
|||
| M1299-10 | Biovision | each | Ask for price |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
|||
| M1299-20 | Biovision | each | Ask for price |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
|||
| M1299-30 | Biovision | each | Ask for price |
Human CD3+ T Cells (Pan T Cells), Cryopreserved |
|||
| M1299-40 | Biovision | each | Ask for price |
Human Umbilical Cord OptiTDS1: Tissue Dissociation System |
|||
| 4-28106 | CHI Scientific | 1 Kit | Ask for price |
Human Umbilical Cord OptiTDS2: Tissue Dissociation System |
|||
| 4-28107 | CHI Scientific | 1 Kit | Ask for price |
Human Umbilical Cord OptiTDS4: Tissue Dissociation System |
|||
| 4-28109 | CHI Scientific | 1 Kit | Ask for price |
Human Umbilical Cord OptiTDS5: Tissue Dissociation System |
|||
| 4-28110 | CHI Scientific | 1 Kit | Ask for price |
Human Umbilical Cord PrimaCell1: Normal Umbilical Artery Endothelial Cells Growth Supplements with Serum (for 500 ml medium) |
|||
| 9-47106 | CHI Scientific | 1 Set | Ask for price |
Human Umbilical Cord PrimaCell4: Normal Umbilical Vein Endothelial Cells Growth Supplements with Serum (for 500 ml medium) |
|||
| 9-47109 | CHI Scientific | 1 Set | Ask for price |
Human ; Umbilical Vein Endothelial Cells |
|||
| 02-701 | Sceti | 100ng | EUR 481.2 |
|
Description: The Human ; Umbilical Vein Endothelial Cells is available in Europe and for worldwide shipping via Gentaur. |
|||
Human Umbilical Vein Endothelial Cells |
|||
| HEC01 | Neuromics | 500,000+ Cells frozen | EUR 528 |
Human Umbilical Cord PrimaCell2: Normal Umbilical Artery Smooth Muscle Cells Growth Supplements with Serum (for 500 ml medium) |
|||
| 9-47107 | CHI Scientific | 1 Set | Ask for price |
Human Umbilical Cord PrimaCell5: Normal Umbilical Vein Smooth Muscle Cells Growth Supplements with Serum (for 500 ml medium) |
|||
| 9-47110 | CHI Scientific | 1 Set | Ask for price |
Mouse Umbilical Cord OptiTDS: Tissue Dissociation System |
|||
| 4-28205 | CHI Scientific | 1 Kit | Ask for price |
Rat Umbilical Cord OptiTDS: Tissue Dissociation System |
|||
| 4-28294 | CHI Scientific | 1 Kit | Ask for price |
Rat Umbilical Cord PrimaCell: Normal Umbilical Vein Smooth Muscle Cells Growth Supplements with Serum (for 500 ml medium) |
|||
| 9-26087 | CHI Scientific | 1 Set | Ask for price |
Mouse Umbilical Cord PrimaCell: Normal Umbilical Vein Smooth Muscle Cells Growth Supplements with Serum (for 500 ml medium) |
|||
| 9-33091 | CHI Scientific | 1 Set | Ask for price |
Cancer Antigen AFP Antigen (Human Cord Blood) |
|||
| VAng-Wyb8624-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Alpha Fetoprotein (66 kDa), Cancer antigen from Human Cord Blood, 1.73 mg/mL. |
|||
GFP Expressing Human Umbilical Vein Endothelial Cells |
|||
| GF01 | Neuromics | 500,000+ Cells frozen | EUR 1248 |
Immortalized Human Umbilical Vein Endothelial Cells - SV40 |
|||
| T0014 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Human Umbilical Cord FibrOut1: Fibroblast Inhibitory System (for 500 ml medium) |
|||
| 7-15095 | CHI Scientific | 1 Kit | Ask for price |
Human Umbilical Cord FibrOut2: Fibroblast Inhibitory System (for 500 ml medium) |
|||
| 7-15096 | CHI Scientific | 1 Kit | Ask for price |
Human Umbilical Cord FibrOut4: Fibroblast Inhibitory System (for 500 ml medium) |
|||
| 7-15098 | CHI Scientific | 1 Kit | Ask for price |
Human Umbilical Cord FibrOut5: Fibroblast Inhibitory System (for 500 ml medium) |
|||
| 7-15099 | CHI Scientific | 1 Kit | Ask for price |
human umbilical vein endothelial cells, Peptide Aptamer, Biotinylated |
|||
| AP-316-B | Alpha Diagnostics | 1 mg | Ask for price |
human umbilical vein endothelial cells, Peptide Aptamer, unlabeled |
|||
| AP-316-U | Alpha Diagnostics | 5 mg | Ask for price |
Sheep Red Blood Cells |
|||
| 20R-RS001 | Fitzgerald | 10 ml | EUR 625.2 |
|
Description: Human IgG Senstitized Gluteraldehyde Stabilized Sheep Red Bllood Cells |
|||
Bovine Red Blood Cells |
|||
| 88R-B002 | Fitzgerald | 20 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Bovine Red Blood Cells |
|||
Chicken Red Blood Cells |
|||
| 88R-C002 | Fitzgerald | 20 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Chicken Red Blood Cells |
|||
Dog Red Blood Cells |
|||
| 88R-D004 | Fitzgerald | 10 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Dog Red Blood Cells |
|||
Goat Red Blood Cells |
|||
| 88R-G003 | Fitzgerald | 20 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Goat Red Blood Cells |
|||
Hamster Red Blood Cells |
|||
| 88R-H001 | Fitzgerald | 5 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Hamster Red Blood Cells |
|||
Horse Red Blood Cells |
|||
| 88R-H002 | Fitzgerald | 20 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Horse Red Blood Cells |
|||
Hamster Red Blood Cells |
|||
| 88R-H003 | Fitzgerald | 10 ml | EUR 586.8 |
|
Description: Washed and freshly prepared 10% suspension of Hamster Red Blood Cells |
|||
Mouse Red Blood Cells |
|||
| 88R-M001 | Fitzgerald | 10 ml | EUR 354 |
|
Description: Washed and freshly prepared 10% suspension of Mouse Red Blood Cells |
|||
Monkey Red Blood Cells |
|||
| 88R-M003 | Fitzgerald | 5 x 2 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Monkey Red Blood Cells |
|||
Mouse Red Blood Cells |
|||
| 88R-M004 | Fitzgerald | 5 x 2 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Mouse Red Blood Cells |
|||
Pig Red Blood Cells |
|||
| 88R-P002 | Fitzgerald | 20 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Pig Red Blood Cells |
|||
Rabbit Red Blood Cells |
|||
| 88R-R001 | Fitzgerald | 20 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Rabbit Red Blood Cells |
|||
Rat Red Blood Cells |
|||
| 88R-R002 | Fitzgerald | 5 x 2.0ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Rat Red Blood Cells |
|||
Rat Red Blood Cells |
|||
| 88R-R005 | Fitzgerald | 25 ml | EUR 392.4 |
|
Description: Washed and freshly prepared 10% suspension of Rat Red Blood Cells |
|||
Sheep Red Blood Cells |
|||
| 88R-S001 | Fitzgerald | 100 ml | EUR 614.4 |
|
Description: Washed and freshly prepared 10% suspension of Sheep Red Blood Cells |
|||
Sheep Red Blood Cells |
|||
| 88R-S003 | Fitzgerald | 20 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Sheep Red Blood Cells |
|||
Sheep Red Blood Cells |
|||
| 88R-S004 | Fitzgerald | 10 ml | EUR 625.2 |
|
Description: Glutaraldehyde-stabilized freshly prepared albumin sensitised Sheep Red Blood Cells |
|||
Sheep Red Blood Cells |
|||
| 88R-S005 | Fitzgerald | 10 ml | EUR 535.2 |
|
Description: Glutaraldehyde-stabilized freshly prepared tanned Sheep Red Blood Cells |
|||
Turkey Red Blood Cells |
|||
| 88R-T001 | Fitzgerald | 20 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Turkey Red Blood Cells |
|||
Mouse Umbilical Cord FibrOut: Fibroblast Inhibitory System (for 500 ml medium) |
|||
| 7-15184 | CHI Scientific | 1 Kit | Ask for price |
Rat Umbilical Cord FibrOut: Fibroblast Inhibitory System (for 500 ml medium) |
|||
| 7-15264 | CHI Scientific | 1 Kit | Ask for price |
human umbilical vein endothelial cells, Peptide Aptamer, FITC labelled |
|||
| AP-316-F | Alpha Diagnostics | 1 mg | Ask for price |
Untransduced T Cells |
|||
| 78170-1 | BPS Bioscience | 1 vial | EUR 1250 |
|
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells. |
|||
Untransduced T Cells |
|||
| 78170-2 | BPS Bioscience | 5 vials | EUR 3325 |
|
Description: The untransduced T cells are produced by mock lentiviral transduction of human primary CD4+CD8+ T cells. These cells are subjected to comparable manipulations as CAR-T cells: activation, spinoculation (without lentivirus), and expansion. These T cells are meant to be negative controls in experiments using lentivirus-transduced primary CAR-T cells. |
|||
CORNING®HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS, HUVEC-2 CELLS (>5X105 CELLS), 1 CRYOVIAL/PACK |
|||
| 354151 | CORNING | 1/pk | EUR 465.6 |
|
Description: Permeable Support - DL; Coated Transwells - DL |
|||
anti-CD3 T-cell |
|||
| 501-A-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: anti-CD3 T-cell |
|||
anti-CD3 T-cell |
|||
| 501-A-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: anti-CD3 T-cell |
|||
CD3, T-Cell; Polyclonal |
|||
| A20030 | ScyTek Laboratories | 2 ml | EUR 156 |
CD3, T-Cell; Polyclonal |
|||
| A00030 | ScyTek Laboratories | 6 ml | EUR 255.6 |
CD3, T-Cell; Polyclonal |
|||
| A00030-0100 | ScyTek Laboratories | 100 ml | EUR 2700 |
CD3, T-Cell; Polyclonal |
|||
| A00030.0025 | ScyTek Laboratories | 25 ml | EUR 745.2 |
Rabbit Red Blood Cells (100%) |
|||
| 20-abx800015 | Abbexa |
|
|
Sheep Red Blood Cells (100%) |
|||
| 20-abx800032 | Abbexa |
|
|
Goat Red Blood Cells (100%) |
|||
| 20-abx800047 | Abbexa |
|
|
Horse Red Blood Cells (100%) |
|||
| 20-abx800062 | Abbexa |
|
|
Horse Red Blood Cells (100%) |
|||
| abx800062-1L | Abbexa | 1 L | EUR 895.2 |
Donkey Red Blood Cells (100%) |
|||
| 20-abx800077 | Abbexa |
|
|
Donkey Red Blood Cells (100%) |
|||
| abx800077-1L | Abbexa | 1 L | EUR 1429.2 |
Camel Red Blood Cells (100%) |
|||
| 20-abx800092 | Abbexa |
|
|
Camel Red Blood Cells (100%) |
|||
| abx800092-1L | Abbexa | 1 L | EUR 3650.4 |
Dog Red Blood Cells (100%) |
|||
| 20-abx800122 | Abbexa |
|
|
Chicken Red Blood Cells (100%) |
|||
| 20-abx800137 | Abbexa |
|
|
Guinea Pig Red Blood Cells |
|||
| 88R-1047 | Fitzgerald | 15 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Guinea Pig Red Blood Cells |
|||
Guinea Pig Red Blood Cells |
|||
| 88R-G002 | Fitzgerald | 25 ml | EUR 438 |
|
Description: Washed and freshly prepared 10% suspension of Guinea Pig Red Blood Cells |
|||
Guinea Pig Red Blood Cells |
|||
| 88R-P001 | Fitzgerald | 15 ml | EUR 327.6 |
|
Description: Glutaraldehyde-stabilized freshly prepared Guinea Pig Red Blood Cells |
|||
Neural Stem Cells (iPSC from Blood Cells; Male) |
|||
| ASE-9234 | Applied StemCell | 1 vial (1 x 10^6) | EUR 497.4 |
|
Description: 12 month |
|||
Neural Stem Cells (iPSC from Blood Cells; Female) |
|||
| ASE-9234F | Applied StemCell | 1 vial (1 x 10^6) | EUR 497.4 |
|
Description: 12 month |
|||
VEGF-stimulated human umbilical vein endothelial cells, Peptide Aptamer, Biotinylated |
|||
| AP-339-B | Alpha Diagnostics | 1 mg | Ask for price |
VEGF-stimulated human umbilical vein endothelial cells, Peptide Aptamer, unlabeled |
|||
| AP-339-U | Alpha Diagnostics | 5 mg | Ask for price |
Normal Human Peripheral Blood Mononuclear Cells, Frozen -100 million cells |
|||
| 79059-2 | BPS Bioscience | 100 million cells | EUR 580 |
|
Description: Cryopreserved vial (30 x 10^6 cells) of freshly isolated primary human peripheral blood mononuclear cells (PBMCs) from a healthy donor, isolated from leukapheresis / apheresis samples using Ficoll gradient. After isolation, the PBMCs were stained to identify sub populations and evaluated for viability by flow cytometry. Cells were cryopreserved in serum-free Cryostor CS10 at a controlled rate. |
|||
Normal Human Peripheral Blood Mononuclear Cells, Frozen |
|||
| 79059-1 | BPS Bioscience | 30 million cells | EUR 220 |
|
Description: Cryopreserved vial (30 x 10^6 cells) of freshly isolated primary human peripheral blood mononuclear cells (PBMCs) from a healthy donor, isolated from leukapheresis / apheresis samples using Ficoll gradient. After isolation, the PBMCs were stained to identify sub populations and evaluated for viability by flow cytometry. Cells were cryopreserved in serum-free Cryostor CS10 at a controlled rate. |
|||
Rabbit RED BLOOD CELLS HEPARIN 500mL* |
|||
| 31159-5 | Pel-Freez | 500mL | EUR 986.28 |
Beagle dog Red Blood Cells (100%) |
|||
| 20-abx800107 | Abbexa |
|
|
Neurons (iPSC from Blood Cells; Male) |
|||
| ASE-9321 | Applied StemCell | 1 vial (1 x 10^6) | EUR 375.9 |
|
Description: 12 month |
|||
Neurons (iPSC from Blood Cells; Female) |
|||
| ASE-9321F | Applied StemCell | 1 vial (1 x 10^6) | EUR 375.9 |
|
Description: 12 month |
|||
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
| 516-A-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
| 516-A-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
VEGF-stimulated human umbilical vein endothelial cells, Peptide Aptamer, FITC labelled |
|||
| AP-339-F | Alpha Diagnostics | 1 mg | Ask for price |
Genetic Variation Analysis VPR between China Major Supply Recombinants CRF01_AE and CRF07_BC.
HIV-1 recombinant strains CRF07_BC CRF01_AE and is responsible for over 80% of new infections in China since the early 2000s. Both strains may have a different genetic mutations that lead to different patterns of pathogenesis-related virus gene, Vpr.The amino acid patterns and genetic diversity VPR analyzed and characterized CRF01_AE HIV-1 and HIV-1 strains.
The CRF07_BC VPR gene amplified from RNA virus was extracted and DNA sequencing performed using ABI3730 analysis. The composition of amino acid positions, and the genetic variation within VPR sequences were analyzed by Bio-Editing Software 7.2 and 6.01 Mega Total packages.A of 162 CRF01_AE and 80 CRF07_BC VPR derived sequence obtained by DNA sequencing. CRF01_AE patients showed a higher viral loads and lower CD4 cell counts than patients CRF07_BC (P <0.05).
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC942083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCA2083-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), APC conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC552083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC552083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC612083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC612083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCP2083-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCR2083-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC402083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC402083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC432083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC432083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC052083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC052083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC812083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC812083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC802083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC802083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCH2083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCH2083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC042083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC042083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC682083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC682083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC702083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC702083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCAP2083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCAP2083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC882083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC882083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC472083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNC472083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCB2083-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNCB2083-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNUB2083-100 | Biotium | 100uL | EUR 316.8 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), Concentration: 0.2mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNUB2083-50 | Biotium | 50uL | EUR 486 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), 1mg/mL |
|||
CD86 (Dendritic Cells Maturation Marker) (rC86/1146) Antibody |
|||
| BNUB2083-500 | Biotium | 500uL | EUR 615.6 |
|
Description: Primary antibody against CD86 (Dendritic Cells Maturation Marker) (rC86/1146), Concentration: 0.2mg/mL |
|||
Mouse Anti Rat Follicular Dendritic Cells Monoclonal Antibody |
|||
| DMABT-49803MR | Creative Diagnostics | 0.25 mg | EUR 920.4 |
Mouse Anti Human Follicular Dendritic Cells Monoclonal Antibody |
|||
| DMABT-52181MH | Creative Diagnostics | 0.2 mg | EUR 1431.6 |
Mouse Anti Human Follicular Dendritic Cells Monoclonal Antibody |
|||
| DMABT-52196MH | Creative Diagnostics | 25 µg | EUR 446.4 |
Mouse Anti Human Follicular Dendritic Cells Monoclonal Antibody |
|||
| DMABT-52197MH | Creative Diagnostics | 0.2 mg | EUR 889.2 |
Rat Anti Mouse Dendritic/Interdig. Cells Monoclonal Antibody |
|||
| DMABT-54517RM | Creative Diagnostics | 2 ml | EUR 920.4 |
Anti-CD86 (Dendritic Cells Maturation Marker) Monoclonal Antibody |
|||
| M00220 | BosterBio | 100ug/vial | EUR 476.4 |
|
Description: Mouse Monoclonal CD86 (Dendritic Cells Maturation Marker) Antibody. Validated in Flow Cytometry, IP and tested in Human, Mouse, Rat. |
|||
Human Cord Blood CD34+ Cells Derived Endothelial Cells |
|||
| HEC23 | Neuromics | 500,000+ Cells | EUR 1296 |
Mesenchymal Stem Cells - Adipose Derived |
|||
| SC00AD1 | Neuromics | 500,000 Cells | EUR 1086 |
Mesenchymal Stem Cells - Placental Derived |
|||
| SC00P1 | Neuromics | 500,000 cells | EUR 1086 |
Monoclonal CD86 (Dendritic Cells Maturation Marker) Antibody, Clone: BU63 |
|||
| APR10944G | Leading Biology | 7 ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD86 (Dendritic Cells Maturation Marker). The antibodies are raised in Mouse and are from clone BU63. This antibody is applicable in WB, IHC and IF, FC, IP |
|||
Endothelial-Monocyte-Activating Polypeptide II-Derived Peptide |
|||
| H-2278.0001 | Bachem | 1.0mg | EUR 618 |
|
Description: Sum Formula: C81H142N26O22; CAS# [155029-52-0] |
|||
Endothelial-Monocyte-Activating Polypeptide II-Derived Peptide |
|||
| H-2278.0005 | Bachem | 5.0mg | EUR 2358 |
|
Description: Sum Formula: C81H142N26O22; CAS# [155029-52-0] |
|||
Mesenchymal Stem Cells - Bone Marrow Derived |
|||
| SC00BM1 | Neuromics | 500,000 cells | EUR 1086 |
Human Mesenchymal Stem Cells - Bone Marrow Derived |
|||
| MSC001 | Neuromics | 500,000+ Cells | EUR 1545.6 |
Immortalized mouse adipose-derived mesenchymal cells (iMADs) |
|||
| T0541 | ABM | 1x106 cells / 1.0 ml | Ask for price |
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC941781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC941781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCA1781-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),APC conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC551781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC551781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC611781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC611781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNUM1781-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781), 1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCP1781-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCR1781-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),RPE conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC431781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC431781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC051781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC051781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC401781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC401781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC811781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC811781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC801781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC801781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCH1781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCH1781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC041781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC041781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC681781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC681781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC701781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC701781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCAP1781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCAP1781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC881781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC881781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCB1781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNCB1781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC471781-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNC471781-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781),CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNUB1781-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781), Concentration: 0.2mg/mL |
|||
CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781) Antibody |
|||
| BNUB1781-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) (C209/1781), Concentration: 0.2mg/mL |
|||
Anti-CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) Monoclonal Antibody |
|||
| M01025 | BosterBio | 100ug/vial | EUR 476.4 |
|
Description: Mouse Monoclonal CD209 / DC-SIGN (Pathogen Receptor on Dendritic Cells) Antibody. Validated in IHC and tested in Human. |
|||
Anti Rat Macrophage/Dendritic Cells Monoclonal Antibody (Clone No. RM-4) |
|||
| KT014 | Sceti | each | EUR 778.8 |
|
Description: The Anti Rat Macrophage/Dendritic Cells Monoclonal Antibody (Clone No. RM-4) is available in Europe and for worldwide shipping via Gentaur. |
|||
Immortalized Mouse Myeloid-derived Suppressor-like (HD1A) Cells |
|||
| T0137 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Pancreatic Islet-Derived Precursor Cells - SV40 |
|||
| T0162 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Pancreatic Islet-Derived Precursor Cells - hTERT |
|||
| T0163 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Pancreatic Islet-Derived Precursor Cells - Myc |
|||
| T0164 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Pancreatic Islet-Derived Precursor Cells - Ras |
|||
| T0165 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Immortalized Human Pancreatic Islet-Derived Precursor Cells - EBV |
|||
| T0166 | ABM | 1x106 cells / 1.0 ml | Ask for price |
Genetic distances were higher and more polymorphic amino acid found in CRF01_AE of CRF07_BC VPR VPR (P <0.05). Conservative amino acid region identified as 29EAVRHFP35 common in both CRF07_BC and CRF01_AE. Of note, R77Q mutations found in both the most recent and China are CRF07_BC Vpr.CRF01_AE CRF01_AE comes VPR has a higher genetic variation and pathogenesis compared with CRF07_BC strain.